Stage 0 Fallopian Tube Cancer

Known as: Fallopian Tube Carcinoma in Situ, Stage 0 Fallopian Tube Cancer AJCC v7, Tubal Intraepithelial Carcinoma 
Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (limited to tubal mucosa). N0: No regional lymph node metastasis. M0: No distant metastasis… (More)
National Institutes of Health

Related topics

Related topics

14 relations
Carcinoma in SituEpithelial CellsEpitheliumFallopian Tubes
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
A precursor for invasive ovarian/pelvic high-grade serous carcinoma, termed serous tubal intraepithelial carcinoma (STIC), has… (More)
Is this relevant?
2014
2014
Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during…
Early detection of sporadic pelvic serous carcinoma remains an elusive goal. In women at high risk for hereditary breast and… (More)
  • table 1
  • table 3
  • table 2
  • table 5
  • table 5
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
High-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges. Although the traditional model of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis.
Pelvic serous carcinoma is usually advanced stage at diagnosis, indicating that abdominal spread occurs early in carcinogenesis… (More)
Is this relevant?
2010
2010
HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes.
Before high-grade papillary serous carcinoma (HG-PSC) becomes invasive, it is believed to be a poorly defined short-lived… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2009
2009
Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
SUMMARY Most serous adenocarcinomas involving both the endometrium and ovary are presumed to arise in the endometrium. Recently… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
OBJECTIVES Pelvic serous carcinomas are classified according to the location of greatest mass of tumor as ovarian, peritoneal or… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
The tubal fimbria is a common site of origin for early (tubal intraepithelial carcinoma or TIC) serous carcinomas in women with… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
Proposed origins of pelvic serous carcinoma include the ovary, fallopian tube, and peritoneum. Prophylactic salpingo… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
1984
Review
1984
OVARIAN CANCER
Ovarian cancer is not a single disease and can be subdivided into at least five different histological subtypes that have… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?